There is accumulating evidence showing that the majority of cell death in neural grafts results from apoptosis when cells are implanted into the brain. Tauroursodeoxycholic acid (TUDCA), a taurine-conjugated hydrophilic bile acid, has been found to possess antiapoptotic properties. In the present study we have examined whether the supplementation of TUDCA to cell suspensions prior to transplantation can lead to enhanced survival of nigral grafts. We first conducted an in vitro study to examine the effects of TUDCA on the survival of dopamine neurons in serum-free conditions. The number of tyrosine hydroxylase (TH)-positive neurons in the TUDCA-treated cultures was significantly greater than that of control cultures 7 days in vitro. In addition, a terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) assay showed that the number of apoptotic cells in the TUDCA-treated cultures was dramatically smaller than that in the control cultures. In the transplantation study, a 50 µM concentration of TUDCA was added to the media when nigral tissue from Sprague-Dawley (SD) rats was trypsinized and dissociated. Two microliters of cell suspension containing TUDCA was then stereotaxically injected into the striatum of adult SD rats subjected to an extensive unilateral 6-hydroxydopamine lesion of the nigrastriatal dopamine pathway. At 2 weeks after transplantation, the rats that received a cell suspension with TUDCA exhibited a significant reduction in amphetamine-induced rotation scores when compared with pretransplantation value. There was a significant increase (approximately threefold) in the number of TH-positive cells in the neural grafts for the TUDCA-treated group when compared with the controls 6 weeks postgrafting. The number of apoptotic cells was much smaller in the graft areas in the TUDCA-treated groups than in the control group 4 days after transplantation. These data demonstrate that pretreatment of the cell suspension with TUDCA can reduce apoptosis and increase the survival of grafted cells, resulting in an improvement of behavioral recovery.
INTRODUCTION
(9, 32, [40] [41] [42] 46 ). The precise mechanisms underlying this poor survival rate need to be further elucidated. In a recent review, it has been estimated that a minimum Transplantation of human embryonic dopamine neurons in patients with Parkinson's disease (PD) is curof 80,000 dopamine neurons is required for manifested clinical benefits (6). However, several clinical studies rently being evaluated in clinical trials (6). Although it has been reported that a small number of patients with have demonstrated that the number of surviving dopamine neurons in the brain is far smaller than this number PD exhibit a normalization of dopamine content in the brain and return to a normal life after neural transplantain patient specimens (23). The enhancement of dopamine neuron survival therefore becomes a pertinent issue (12). tion (28, 34) , the majority of transplanted patients show incomplete symptomatic recovery (23, 30) . Several facIn addition, the improvement of dopamine neuron survival can circumvent the limited availability of human embrytors may contribute to this limitation. Among them, the loss of transplanted dopamine neurons remains one of onic dopamine tissue, which is a major obstacle in the clinical application of neural transplantation. the main obstacles to a complete clinical improvement.
Numerous animal experimental and clinical studies have
There is substantial evidence that apoptosis plays a critical role in the loss of transplanted dopamine neurons shown that the survival rate of grafted dopamine (DA) neurons is only about 10% when DA neurons are im- (22, 31, 42, 45) . It has been demonstrated that the number of implanted dopamine neurons increases by severalplanted into the brain using a cell suspension technique fold when apoptotic pathways are disrupted by using cassota and conducted under the auspices of Research Animal Resources, a facility approved by the American Aspase inhibitors (42) or antiapoptotic agents (20, 45) . In addition, apoptosis normally takes place within the first sociation for the Accreditation of Laboratory Animal Care. several days after transplantation (22, 42, 45) . In an in vitro study apoptosis associated with the loss of DA neuCell Culture Experiments. In order to examine the rons was found to occur predominantly during the first effects of TUDCA on apoptosis and the survival of 24 h, and about 50% of the DA neurons were already dopamine neurons in VM tissue cultures under serumlost in the first 8 h (8). These studies provide possible free conditions and to determine the optimal dosage of explanations to the previous observations that the major-TUDCA, primary neuronal cultures were prepared from ity of cell death in nigral grafts occurs immediately after the VM tissue of SD rat embryos and incubated with or transplantation (2, 18) , and strongly suggest that antiwithout the addition of TUDCA (Calbiochem, La Jolla, apoptotic agents should be applied to the preparation of CA, free base, dissolved in 0.15 M NaHCO 3 buffer). In cell suspension prior to transplantation or during the first pilot experiments, the dose-response effects of TUDCA few days after transplantation to prevent apoptosis and were studied and a concentration of 50 µM was found improve graft survival.
to be optimal. Therefore, TUDCA was added to a final Tauroursodeoxycholic acid (TUDCA) is a taurine concentration of 50 µM to the culture medium when the conjugate of the hydrophilic bile acid, ursodeoxycholic culture medium was switched to serum-free conditions acid (UDCA). UDCA is an endogenous bile acid that is after 2 days in vitro. Neural survival and apoptosis were synthesized in the liver. UDCA has been used in the determined by counting tyrosine hydroxylase (TH)-posiclinic for several decades in the treatment of a wide varitive cells and TUNEL-positive cells in the cultures 2 or ety of liver diseases, particularly those associated with 7 days in vitro. A total of three separate series of cell cholestasis (5). It has recently been demonstrated that culture experiments were performed. UDCA possesses antiapoptotic properties (3, 4, 35, 36) . Although the mechanisms underlying antiapoptosis by this Transplantation Experiment. Twenty-four adult female Sprague-Dawley (SD) rats, weighing about 250 g bile acid are not fully understood, several lines of evidence have shown that the actions of this bile acid mainly at the beginning of the experiments, were used as recipients of neural grafts. Among them, 12 rats were subjected involve the protection of mitochondria from dysfunction (35, 36) . These molecules can reduce mitochondrial perto an extensive unilateral 6-hydroxydopamine (6-OHDA) lesion of the mesostriatal dopamine (DA) system and 12 meability transition, preserve mitochondrial membrane potential, and inhibit mitochondria-associated Bax prorats were normal. The 6-OHDA-lesioned rats and normal rats were randomly assigned to the TUDCA-treated tein translocation and caspase activation (35) (36) (37) (38) . In addition, UDCA has also been found to retain an inhibitory (n = 6 in each group) or the vehicle control (n = 6 in each group) group, respectively. The rats were housed effect on the production of reactive oxygen species (36) . Because substantial evidence indicates that apoptosis two per cage under a 12-h day/night cycle with ad libitum access to food and water. They were maintained plays a crucial role in the loss of dopamine neurons in vitro and in vivo, we therefore used the serum-free in and treated in accordance with published National Institutes of Health guidelines. vitro model and the in vivo transplantation model to address the question of whether the application of TUDCA For the TUDCA-treated rats, a 50 µM concentration of TUDCA was added to the medium when nigral tissue can block apoptotic pathways in the cultures and in the grafts, leading to the enhancement of dopamine neuron was trypsinized and dissociated. Two microliters of cell suspension containing TUDCA was then stereotaxically survival and the improvement of nigral graft function.
injected into the striatum of SD rats. For the control ani-MATERIALS AND METHODS mals, the same amount of vehicle solution was added to Experimental Design the medium. In the first series of transplantation experiment, normal rats that received neural transplants were In the present study, cell culture and transplantation experiments were conducted. In both the in vitro and sacrificed 4 days postgrafting and brain sections were prepared for terminal deoxynucleotidyl transferase (TdT)-in vivo studies, ventral mesencephalic (VM) tissue was dissected from Sprague-Dawley (SD) (Charles River mediated dUTP-biotin nick end labeling (TUNEL) assay to determine apoptosis in the transplantation areas. In Labs, Wilmington, MA) rat embryos at embryonic day 14 under sterile conditions as previously described (7, the second series of transplantation experiments, an amphetamine-induced rotation test was used to assess the 14,24). For each experiment, the harvested tissue pieces were equally divided into two experimental groups: concompleteness of the 6-OHDA lesions prior to grafting and repeated 2 and 6 weeks after transplantation to montrol and TUDCA treated. The study was approved by the Animal Care Committee at the University of Minneitor functional effects of the neural grafts. The rats were sacrificed after the last session of the rotational behavtry scores (the number of turns contralateral to the lesioned side subtracted from the number of turns ipsilatioral test and the brain tissue was processed for TH immunocytochemistry. Graft survival was assessed by couneral to the lesioned side). The rotational test was then repeated at two different time points as mentioned in the ting the number of TH-positive neurons in the grafts. experimental design. Rats that displayed a reduction in Ventral Mesencephalic Tissue Cultures rotational asymmetry to less than 50% of the pretransFor each experimental series, pooled VM tissue from plantation value were considered to have functional grafts. 24-32 embryos was incubated in 0.1% trypsin (Sigma, Nigral Tissue Preparation and Transplantation St. Louis, MO)/0.05% DNase (Sigma) at 37°C for 20 min and mechanically dissociated using a 1-ml Gilson A cell suspension technique was used to perform the neural transplants as previously described (7,14). Briefly, pipette. Following dissociation, the cells were centrifuged at 600 rpm for 5 min and the pellet was resus-VM tissue was obtained from embryos with a crown-torump length of 13-14 mm, corresponding to a gestapended in DMEM. The cell number and viabilities of dissociated cells were assessed with a hemocytometer tional age of embryonic day 14. Dissection and preparation of the donor tissue were carried out under aseptic using trypan blue dye exclusion. Cells (100,000 cells/ cm 2 ; 178,000 cells per well) were plated onto four-well conditions in Hank's balanced salt solution (HBSS, Gibco). Uterine horns were removed by hysterectomy chamber slides (Nunc, Rochester, NY) precoated with 10 mg/ml poly-D-lysine (Sigma). The viabilities of disfrom the animals under deep chloral hydrate anesthesia (250 mg/kg, IP) and placed in plastic tubes containing sociated cells were over 95%. Cell cultures were incubated for 2 days in DMEM supplemented with 10% fetal HBSS. The embryos were removed from the uterus and embryonic brains were individually transferred to a petri calf serum at 37°C in a 95% air/5% CO 2 humidified atmosphere. After 2 days in vitro, the culture medium dish with a dark background. The VM was dissected out from each brain under a dissection microscope using was switched to serum-free N2 medium, consisting of DMEM/Ham's F 12 (1:1) mixture (Gibco, Carlsbad, CA).
iridectomy scissors and fine watchmaker's forceps. The dissected pieces were pooled and incubated in 0.1% At this time point, some cultures were supplemented with TUDCA.
trypsin (Sigma)/0.05% DNase (Sigma)/HBSS at 37°C for 20 min. After rinsing four to five times with 0.05% Unilateral 6-OHDA Lesion DNase/HBSS, the tissue was gently dissociated to a mixture of single cells and small cellular aggregates usTwo injections of 6-OHDA (hydrochloride salt, Sigma) were made into the right ascending mesostriatal ing fire-polished Pasteur pipettes with an inner diameter of 0.5-1.0 mm. The final solution of the cell suspension DA pathway under equithesin anesthesia (0.3 ml/100 g body weight, IP) as described previously (17) . Briefly, was adjusted so that 5 µl of HBSS was added for each dissected piece of VM tissue. Before and after transplana first injection of 2.5 µl of 6-OHDA (3 µg/µl, free base, in 0.2 mg/ml ascorbate-saline) was performed at the foltation, the viabilities of the cell suspensions were assessed by the trypan blue dye exclusion method. The lowing coordinates: 4.4 mm caudal to bregma, 1.2 mm lateral to midline, 7.8 mm ventral to the dural surface, viabilities of all the cell suspensions in this study were over 95%. with the tooth-bar set at 2.4 mm below the interaural line. A second injection of 2 µl of 6-OHDA was perOne deposit of 2 µl of the cell suspension (containing ϳ100,000 cells, equivalent to one third of VM) was steformed at the following coordinates: 4.0 mm caudal to bregma, 0.8 mm lateral to midline, 8.0 mm ventral to reotaxically implanted into the right striatum of equithesin (3 ml/kg, IP)-anesthetized recipient rats fixed in the dural surface, with the tooth-bar set at 3.4 mm above the interaural line. The 6-OHDA was infused at a rate a Kopf stereotaxic frame. Using a 10-µl Hamilton microsyringe (Hamilton Co., Reno, NV) fitted with a steel of 1 µl/min, and the cannula was left in place for an additional 4 min before it was withdrawn.
cannula (inner diameter = 0.25 mm, outer diameter = 0.47 mm), injections were made at the following coordiAmphetamine-Induced Rotation Tests nates: 1.0 mm rostral to bregma, 3.0 mm lateral to the midline, 4.5 mm ventral to the dural surface, with the Two to 3 weeks after the lesion surgery, the rats were tooth-bar set at zero. The injection was performed over given 5 mg/kg of d-amphetamine sulphate (Sigma) in 2 min and the needle was left in place for an additional saline, IP, and their rotational behavior was monitored 2-4 min before retraction. in automated rotometer bowls for 90 min (43). Twelve rats that exhibited a net rotational asymmetry of at least Immunocytochemistry seven full ipsilateral turns per minute towards the lesioned side were selected and divided into two groups
The avidin-biotin complex immunoperoxidase technique was used to visualize immunocytochemical staining that were balanced according to net rotational asymme-as described previously (20). For the cell culture experiCell Counts. For the cell culture experiments, the number of TH-positive cells and the total cells were asments, cultures were rinsed once with phosphate-buffered saline (PBS, 0.2 M, pH 7.4), followed by fixation with sessed at 20× and 40× magnification, respectively, with the aid of a 400-µm square reticule grid as described 4% formaldehyde for 20 min at room temperature. Then cultures were processed for immunocytochemistry. For previously (24) . Eight fields were selected in order to sample a representative area of each culture well in a the transplantation experiments, rats were deeply anesthetized with chloral hydrate at a lethal dose (500 mg/ systematic fashion. The sampled areas made up 1-3% of the total area of each well. For the transplantation kg, body weight, IP) and transcardially perfused with 0.1 M PBS followed by cold 4% formaldehyde. The experiments, TH-positive neurons in the grafts were counted on every fourth section using a 10× objective brains were then removed and postfixed for 4 h in the same fixative, and placed in 20% sucrose at 4°C until lens in a Nikon light microscope (Nikon, Japan). Cells were counted only when they exhibited at least one neuthey sank. Sections were coronally cut at 30 µm thickness on a freezing sliding microtome. Throughout the rite or had a visible nucleus. After measurement of the average diameter of TH-immunoreactive cells with an region of the graft, four adjacent series of sections were collected in four glass vials. The following primary antiinserted grid using a 20× objective lens, total numbers of TH-immunoreactive neurons were calculated by mulbodies were used against TH (1:500 Pel-Freez, Rogers, AR). Biotinylated goat anti-rabbit (rat-absorbed) immutiplying the raw counts with a correction factor (2.8) according to the Abercrombie formula (1). noglobulins (1:200) (Vector Laboratories, Inc., Burlingame, CA) were used as the secondary antibody. Sec-TUNEL-Positive Cell Counts. For the cell culture extions were incubated in ABC solution (Vectastain ABC periments, the number of TUNEL-positive cells was asElite kit, Vector Laboratories Inc.) followed by developsessed at 400× magnification with the aid of a 400-µm ment with 3,3′-diaminobenzidine solution (Vectastain square reticule grid. Six fields were selected from each DAB kit, Vector Laboratories Inc.) to visualize the imculture well in a systematic fashion. For the transplantamunoreactive products. After staining, sections were tion experiments, TUNEL-positive cells in the graft armounted on superfrost microscope slides (Fisher Scieneas were counted in three to four sections per animal. tific, Pittsburgh, PA), dehydrated through ascending Average number of TUNEL-positive cells was calcugraded concentrations of alcohol, cleared in xylene, and lated and represented a value for single animals. coverslipped using DPX mounting medium (Fluka, Volumetric Analyses. The volume of intrastriatal Switzerland).
neural grafts was analyzed using a computer-assisted image analysis system as described previously (19) .
TUNEL Assay
Briefly, all the TH-immunostained sections with grafts TUNEL assay was performed by using an ApopTag  were digitized using a 1× objective lens under a Nikon in situ Apoptosis Detection Kit according to the manulight microscope (Nikon, Japan) that was connected with facturer's protocol (Intergen, Purchase, NY) as dea high-resolution digital camera (COOLPIX 950, Nikon, scribed previously (20). Briefly, three to four sections Japan). The images were first collected and stored in a containing graft tissue were selected from each grafted CompactFlash card. Then the CompactFlash card was animal 4 days postgrafting. They were mounted on suread by using a CompactFlash card reader connected perfrost microscope slides (Fisher Scientific) for the folwith a Pentium III PC (Dell, Dimension XPS T700r, lowing staining protocol. The sections were first quenched USA) and the images were analyzed using a software in 3% hydrogen peroxide in PBS to remove endogenous package (Scion Image, Version Beta 4.0.2, Scion Corpoperoxidase, and then subsequently incubated in working ration, Frederick, MD). In each section, the graft was strength TdT enzyme and peroxidase-conjugated antimanually outlined on the screen and the surface area body against digoxigenin solution. 3,3′-Diaminobenzimeasured. The number of pixels was subsequently condine (Sigma) was used as a chromogen to visualize the verted into square millimeters. The graft volume was reactive products. After counterstaining with methyl green, calculated based on graft area, section thickness, and frethe sections were dehydrated in alcohol and cleared in quency. xylene and coverslipped using Permount mounting meStatistical Analysis dium (Fisher Scientific, Fair Lawn, NJ).
Data in the text and figures are expressed as means ± Morphological Assessment SEM. Statistical comparisons were performed parametrically using two-factor analysis of variance (ANOVA); In order to avoid subjective bias in the interpretation of the results, all of the morphological assessments were one-factor ANOVA followed a post hoc Scheffé's F-test or a Student's t-test for a group-wise comparison. Statisconducted under a microscope with bright-field illumination on stained sections in a blinded manner (20).
tical significance level was set at p < 0.05.
RESULTS
exerted this neural protective effect in a dose-dependent manner (data not shown).
Cell Culture Experiments
Apoptosis. As illustrated in Figure 2 , the number of Dopamine Neuron Survival. At 2 days in vitro, TH-TUNEL-positive cells was significantly higher in 7 DIV positive cells possessed short processes, indicating that control cultures than that in 2 DIV control and 7 DIV they were in an early developmental stage. Some pro-TUDCA-treated cultures (p < 0.01, one-factor ANOVA cesses contacted processes from other cells in their viwith post hoc Scheffé's F-test). cinity (Fig. 1A) . At 7 days in vitro, dopamine neurons exhibited more mature morphology. They sent out sevTransplantation Experiment eral long processes with clear varicosities (Fig. 1B, C) . At this time point, some of the cell bodies and processes
Rotational Behavior. The amphetamine-induced rotation asymmetry scores are summarized in Figure 3 . At appeared granular under phase contrast, possibly indicating that they were undergoing degeneration. There was 2 weeks after transplantation, four of six TUDCAtreated rats exhibited at least 50% reduction in net motor a significant cell loss for TH-positive neurons and total cells in 7 days in vitro (7 DIV) control cultures (p < asymmetry when compared with pretransplantation values. In contrast, none of the control animal showed 50% 0.01, one-factor ANOVA with post hoc Scheffé's F-test). Indeed, the number of TH-immunopositive neurons was reduction in motor asymmetry. At 6 weeks following transplantation, all rats of both the control and the only 30% of the value in 2 DIV cultures. This dramatic cell loss was not observed in 7 DIV TUDCA-treated TUDCA-treated groups exhibited >50% reduction in motor asymmetry scores. cultures (Fig. 1C) . No difference was found in the number of TH-positive cells between 2 DIV cultures and A two-factor ANOVA revealed a significant Group × Time interaction of the net rotational scores over the TUDCA-treated cultures (p > 0.05) (Fig. 1D) . TUDCA treated group than that in the control group [one-factor ANOVA test followed by a post hoc Scheffé's F-test, F(1, 10) = 8.22, p < 0.05]. At 6 weeks after transplantation, the grafts in the control animals exhibited a typical morphology of nigral grafts. The majority of TH-immunopositive neurons were located at the periphery of the grafts, leaving the center of the grafts relatively devoid of TH immunoreactivity (Fig. 4D) . However, it seemed that the grafts in the TUDCA-treated animals lacked this typical morphology of nigral grafts at this time point. Most TUDCA-treated animals showed an even distribution of TH-immunoreactive neurons in the graft area (Fig. 4C) . The TH-immunoreactive neurons possessed multipolar cell bodies with several clearly stained neurites (Fig. 4E) . The areas of the host striatum that were cells in the grafted areas is summarized in Figure 6C for the control and TUDCA-treated groups 4 days posttransplantation. The number of apoptotic cells was signifitesting period, F(1, 2) = 43.83, p < 0.001, indicating that cantly smaller in the TUDCA-treated group than in the the TUDCA-treated rats exhibited a more rapid behavcontrol group [one-factor ANOVA test followed by a ioral recovery than the control rats. Indeed, the mean net post-hoc Scheffé's F-test, F(1, 10) = 20.06, p< 0.01]. A rotation values were significantly reduced 2 weeks after grafting when compared with pregrafting values in the TUDCA-treated group (p < 0.01, paired Student's t-test) but not in the control group (p > 0.05). In addition, a one-factor ANOVA with post hoc Scheffé's F-test showed that the TUDCA-treated group exhibited lower net asymmetry values than the control group 2 weeks after transplantation, F(1, 10) = 5.51, p < 0.05. At 6 weeks after surgery, both groups had significantly reduced motor asymmetry scores (paired Student's t-test, p < 0.05) and there was no longer any difference between the two groups (one-factor ANOVA, p > 0.05).
Graft Survival. The majority of implants were discernible in the center of striatum and were oval shaped. They contained numerous TH-immunoreactive neurons and fibers (Fig. 4) . A few of implants were misplaced into the overlying corpus callosum and the frontal cortex along the cannula tracks. Figure 5 summarizes the mean number of TH-immunoreactive neurons in the grafts in the control and the TUDCA-treated groups 6 weeks after large number of apoptotic cells with DNA fragmentation in nuclei was clustered and located within the grafts in the control group (Fig. 6B) . Only a few apoptotic cells were observed in several patches within the grafts in the TUDCA-treated group (Fig. 6A) . Occasionally, a few scattered apoptotic cells were found in surrounding host tissue of the grafts in both groups.
DISCUSSION
The present study investigated the effects of TUDCA on the survival of dopamine neurons both in vitro and in vivo. The results show that the application of TUDCA facilitates the survival of dopamine neurons in vitro and in vivo. In addition, TUDCA can significantly reduce apoptosis in VM tissue cultures and within the transplants, suggesting that TUDCA exerts beneficial effects ther supportive evidence to the notion that apoptosis is an increase in the number of dopamine neurons, indicating TUDCA exerts neuroprotective effects on dopamine a major contributor to the loss of dopamine neurons. This dramatic cell loss can be prevented if an antiapopneurons mainly through antiapoptotic mechanisms. Earlier studies have shown that around 80-95% of totic agent is applied to the tissue preparation or immediately after grafting.
grafted DA neurons die following transplantation (9, 32,40-42,46). Cell death in neural grafts has recently The culture system where neuronal death was induced by serum deprivation in mesencephalic cultures is been found to occur in the four phases during the transplantation procedure (12). Nevertheless, substantial eviwell known as an in vitro model to induce apoptosis. This in vitro model has been used extensively to examdence shows that the majority of cell loss occurs within the first few days after transplantation (18, 22, 42, 45) . ine the effects of antiapoptotic agents and neurotrophic factors on apoptosis that occur in the VM tissue cultures Several factors have been demonstrated to contribute to this cell death. Mechanical damage, anoxia, and nutriand the survival of dopamine neurons (8,15,16,42,44). In agreement with previous observations (8,42), the data tional insufficiency during the implantation procedure may lead to immediate cell death and production of rein the present study showed that there was a significant cell loss of dopamine neurons after the culture medium active oxygen species. A variety of free radicals can subsequently cause transplanted dopamine neurons to was switched to serum-free conditions. The TUNEL assay results suggest that the majority of the cell loss undergo apoptotic cell death. Nigral grafts that are implanted into the striatum are heterotopic grafts. The new may possibly result from apoptosis. Recently, Schierle et al. (42) showed that a caspase inhibitor reduced the environment in the striatum may not favor nigral graft survival and the neural grafts may lack sufficient neuroloss of dopamine neurons in VM tissue cultures. By using a neurotrophic strategy, Clarkson et al. (15,16) demtrophic support. Based on this notion, a variety of strategies have been accordingly designed to prevent cell onstrated that the supplement of GDNF reduced apoptosis and, therefore, improved survival in human VM death of neural transplants. Nakao et al. (32) applied lazaroids that have the capacity of inhibiting lipid peroxtissue cultures. Our data support these earlier findings and show that the addition of TUDCA to the cultures idation to the cell suspension preparation, or prepared dopamine neurons from transgenic mice overexpressing leads to a reduction in the number of apoptotic cells and the Cu/Zn superoxide dismutase, an enzyme that detoxiioral recovery of 50% and a plateau recovery level of slightly over 100% is found in the range above 2000 fies oxygen free radicals (33) , and found that the survival rate of neural grafts was significantly improved.
intrastriatal TH-positive graft neurons (40, 41) . This phenomenon may reflect the fact that when a certain numThese studies suggest that oxygen free radicals play an important role in the survival of neural grafts. By adding ber of dopamine neurons survive after transplantation at an early time point, a similar number of transplanted an antiapoptotic agent, a caspase inhibitor to the medium during the preparation of the cell suspension, Schierle dopamine neurons will remain for later time points (18, 20) . These observations highlight the value of applying et al. (42) showed that the survival rate of transplanted dopamine neurons was increased by nearly fourfold neuroprotective strategies to prevent cell loss in neural grafts at early time points after transplantation rather when compared with the controls. With the enhancement of neural graft survival, the caspase inhibitorthan at later time points. Another possible explanation for the apparent discrepancy between cell number and treated animals exhibited greater graft function. In a recent study, we reported that the systemic administration behavior is that a critical level of dopamine innervation is required to induce a behavioral correction. This level of synthetic fibronectin peptide V, which has been shown to possess antiapoptotic properties, can increase the suris achieved at an earlier time point in the grafts treated with TUDCA because there is a greater survival of the vival of neural grafts by approximately twofold (20). In the present study, we supplemented TUDCA to the megrafted cells. As the non-TUDCA-treated cells begin to elaborate additional processes and innervate the host dium during the preparation of cell suspension and showed that the survival of neural grafts was increased striatum, they too will eventually provide a level of innervation that is capable of correcting the locomotor by approximately threefold and the graft function was also improved. These data provide supportive evidence asymmetry, but on a delayed time scale compared with the cells treated with TUDCA. to previous findings that the majority of cell loss in the grafts has been found to closely relate to apoptosis Although the precise mechanisms underlying antiapoptosis by TUDCA remain to be further determined, (42,45).
Another strategy of supplying neurotrophic factors to there is accumulating evidence that this bile acid can reduce apoptosis associated with inhibiting mitochongrafted tissue prior to implantation has also been shown to effectively protect dopamine neurons from cell death drial membrane perturbation (35) . Mitochondria are essential subcellular organelles in controlling the apoptotic (45). By preincubating with a combination of glial cell line-derived neurotrophic factor, insulin-like growth facpathways in many cell types (25, 29) . It has been demonstrated that TUDCA primarily interacts with the mitotor-1 and basic fibroblast growth factor, Zawada et al. showed that the survival of grafted dopamine neuron chondrial membrane to prevent several apoptotic events, including the translocation of the proapoptotic protein was increased by 1.5-fold in rat brain. It appeared that this increase in the survival of nigral grafts is associated Bax, the release of cytochrome c, caspase activation, and the production of reactive oxygen species (36) (37) (38) . Caswith inhibition of apoptosis in the grafts. As it has been shown that antioxidants and antiapoptotic agents can efpase activity plays a critical role in apoptosis (39) . An important pathway for caspase activation involves the fectively prevent cell death of implanted nigral grafts, one can speculate that a combination of treatments may mitochondria (25, 29) . TUDCA has been shown to prevent mitochondrial swelling and disruption of the outer yield additive effects. In a recent study, Hansson et al. indeed observed the additive effects of caspase inhibitor mitochondrial membrane. Membrane stability can inhibit proapoptotic molecules, cytochrome c release, and and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons (26) . The observation lead to changes in cytochrome c-mediated downstream events, such as caspase activity. We have recently about the relationship between the number of TH-positive cell count and the level of behavioral recovery is shown that TUDCA significantly reduces 3-nitropropionic acid (3-NP)-mediated neuronal cell death in striatal consistent with previous findings (32, 33, 41, 42) . The early onset of behavioral effects occurred in the treated tissue cultures. In addition, the systemic administration of TUDCA can reduce striatal degeneration mainly group and all the rats exhibited >50% reduction of net motor asymmetry. Although the mechanisms behind through antiapoptotic mechanisms and ameliorate neurological deficits in a 3-NP-lesioned rat model of Huntingrapid onset of behavioral recovery need to be further evaluated, one possible explanation could be that the adton's disease (27) . As UDCA has been used in the clinic for several decades and demonstrated to improve the ministration of these antiapoptotic agents and neurotrophic factors facilitates the rapid maturation of transsurvival of neural grafts mainly through antiapoptotic mechanisms, it should be considered for clinical applicaplanted dopamine neurons. In addition, previous studies have demonstrated that a certain number of intrastriatal tion of neural transplantation.
As the majority of transplanted dopamine neurons die TH-positive grant neurons is required to induce a behav- claimed that these side effects might be due to the con- ing to the production of a relative excess of dopamine Med. 7:512-513; in the patients' brain. They therefore proposed to trans- 
